✦ LIBER ✦

New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation

✍ Scribed by Kunio Kitamura; Hitoshi Kiyoi; Hitoshi Yoshida; Tadasu Tobita; Akihiro Takeshita; Ryuzo Ohno; Tomoki Naoe

Publisher: Springer
Year: 1997
Tongue: English
Weight: 309 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination decitabine, arsenic trioxide

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study

✍ John S. Welch; Jeffery M. Klco; Feng Gao; Elizabeth Procknow; Geoffery L. Uy; Ke 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Childhood immune thrombocytopenia (ITP) has a favorable outcome in most cases but severe bleeding may occur, mostly in children with very low platelet counts. Although first-line therapies are well defined, management of refractory ITP is not consensual. Vinblastine (VBL) is one second-line treatmen

Fludarabine, cytarabine, and mitoxantron

Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG)

✍ Sebastian Giebel; Malgorzata Krawczyk-Kulis; Maria Adamczyk-Cioch; Beata Jakubas 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 136 KB